AMPH
AMPH
US03209R1032
Amphastar Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 719.887.000 731.967.000
1.7%
Cost of Revenue 363.830.000 358.112.000
1.6%
Gross Profit 356.057.000 373.855.000
4.8%
215.654.000 168.436.000
28.0%
Operating Income 140.403.000 205.419.000
31.7%
Pretax Income 123.624.000 189.764.000
34.9%
Net Income Common Stockholders 98.094.000 159.519.000
38.5%
-- --
--
-- --
--
ende